Pfizer and Insilico Join Forces, Use AI To Identify Drug Targets

New York City-based pharmaceutical giant Pfizer has announced it’s teaming up with AI biotech firm, Insilico Medicine. Insilico CEO, Alex Zhavoronkov says the partnership will bring about “one of the most advanced AI teams internally both in target identification and chemistry.”...